---
figid: PMC4685420__fonc-05-00293-g001
figlink: /pmc/articles/PMC4685420/figure/F1/
number: F1
caption: Schematic summarizing some of the genes and pathways known to influence c-Myc
  cap-independent translation in multiple myeloma (MM). Cytokine activation of key
  signaling pathways, or pathway dysregulation, may affect the levels or activity
  of IRES trans-activating factors (ITAFs), including YB1 (conditions of low Akt activity).
  MNK1-mediated phosphorylation of hnRNPA1 and/or RPS25 increases interaction between
  them and might improve ribosome loading on the c-Myc IRES (). Conventional treatments
  for MM usually inhibit CAP-dependent translation but their impact on CAP-independent
  translation is unknown. BMSC, bone marrow stromal cell.
pmcid: PMC4685420
papertitle: Cap-Independent Translation in Hematological Malignancies.
reftext: Emilie Horvilleur, et al. Front Oncol. 2015;5:293.
pmc_ranked_result_index: '103592'
pathway_score: 0.8420325
filename: fonc-05-00293-g001.jpg
figtitle: Schematic summarizing some of the genes and pathways known to influence
  c-Myc cap-independent translation in multiple myeloma (MM)
year: '2015'
organisms: Homo sapiens
ndex: c91f98f1-df20-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4685420__fonc-05-00293-g001.html
  '@type': Dataset
  description: Schematic summarizing some of the genes and pathways known to influence
    c-Myc cap-independent translation in multiple myeloma (MM). Cytokine activation
    of key signaling pathways, or pathway dysregulation, may affect the levels or
    activity of IRES trans-activating factors (ITAFs), including YB1 (conditions of
    low Akt activity). MNK1-mediated phosphorylation of hnRNPA1 and/or RPS25 increases
    interaction between them and might improve ribosome loading on the c-Myc IRES
    (). Conventional treatments for MM usually inhibit CAP-dependent translation but
    their impact on CAP-independent translation is unknown. BMSC, bone marrow stromal
    cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HNRNPA1
  - MKNK1
  - MYC
  - IL6
  - YBX1
  - AKT2
  - AKT1
  - RPS25
  - IGF1
  - AKT3
  - PTBP1
  - MTOR
  - Thalidomide
  - Rapamycin
genes:
- word: hnRNPA1
  symbol: hnRNPA1
  source: hgnc_alias_symbol
  hgnc_symbol: HNRNPA1
  entrez: '3178'
- word: MNK1
  symbol: MNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MKNK1
  entrez: '8569'
- word: C-MYC
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: YB1
  symbol: YB-1
  source: hgnc_alias_symbol
  hgnc_symbol: YBX1
  entrez: '4904'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RPS25
  symbol: RPS25
  source: hgnc_symbol
  hgnc_symbol: RPS25
  entrez: '6230'
- word: IGF1.
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PTB1
  symbol: PTB-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTBP1
  entrez: '5725'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Thalidomide
  source: MESH
  identifier: D013792
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC4685420__F1
redirect_from: /figures/PMC4685420__F1
figtype: Figure
---
